Siren Biotechnology
Signal active
Organization
Contact Information
Overview
Siren Biotechnology blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.AAV gene therapy and cytokine immunotherapy are two revolutionary treatment approaches that Siren Biotechnology has combined into a single, redesigned modality. This approach overcomes significant obstacles and entirely transforms how tumor cells are eliminated and anti-tumor immunity is stimulated.
About
Industries
Biotechnology, Medical, Product Research
Founded
2020
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Siren Biotechnology headquartered in United States, North America, operates in the Biotechnology, Medical, Product Research sector. The company focuses on Biotechnology and has secured $1.1B in funding across 48 round(s). With a team of 1-10 employees, Siren Biotechnology is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Siren Biotechnology, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
4
Investors
1
Lead Investors
0
Total Funding Amount
$23.6M
Details
2
Siren Biotechnology has raised a total of $23.6M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Seed | |||
| 2024 | Seed | 19.6M |
Investors
Siren Biotechnology is funded by 11 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Savantus Ventures | - | FUNDING ROUND - Savantus Ventures | undefined |
| Siren Biotechnology | - | FUNDING ROUND - Siren Biotechnology | 4.0M |
| Siren Biotechnology | - | FUNDING ROUND - Siren Biotechnology | undefined |
| MilliporeSigma | - | FUNDING ROUND - MilliporeSigma | undefined |
Recent Activity
There is no recent news or activity for this profile.